Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SoleoRare is a dedicated rare disease specialty pharmacy launched in April 2026 by Soleo Health. The company consolidates experienced rare disease patient care, patient access, and commercial teams under a clinician-led, patient-centered care model designed specifically for rare, ultra-rare, and orphan disease patients and their caregivers. Operating as a clinical and commercial partner for pharmaceutical manufacturers, SoleoRare provides specialized distribution channels, complex therapy management, and infusion services. It leverages Soleo Health's national footprint of pharmacy locations, ambulatory infusion suites, and nursing coverage across all 50 U.S. states to deliver high-quality, coordinated care in patients' homes or alternate sites.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SoleoRare.